论文部分内容阅读
目的:分析康复新液联合泮托拉唑治疗消化性溃疡的疗效及安全性。方法:选取我院2016-2017年3月接受并进行治疗的118例消化性溃疡患者,随机分为观察组59例,用奥美拉唑联合果胶铋治疗,对照组59例,用康复新液联合泮托拉唑治疗,连续服用2周,根据检查结果,同时结合临床症状,判断临床疗效;患者服药后头晕、腹胀、呕吐、食欲减退的情况评价安全性。结果:观察组治疗总有效率91.53%高于对照组74.58%(P<0.05);观察组治疗总不良反应为8.47%,低于对照组38.98%(P<0.05)。结论:对于消化性溃疡患者,采取康复新液联合泮托拉唑治疗具有显著的疗效,安全性高,值得临床推广应用。
Objective: To analyze the efficacy and safety of Kangfuxin solution combined with pantoprazole in the treatment of peptic ulcer. Methods: A total of 118 patients with peptic ulcer who were treated and treated in our hospital from March 2016 to March 2017 were randomly divided into observation group (n = 59), omeprazole combined with pectin and bismuth (n = 59), control group (n = 59) Liquid combination of pantoprazole treatment, taking two consecutive weeks, according to the test results, combined with clinical symptoms, to determine the clinical efficacy; patients dizziness, bloating, vomiting, loss of appetite after the evaluation of safety. Results: The total effective rate of observation group was 91.53% higher than 74.58% of control group (P <0.05). The total adverse reaction rate of observation group was 8.47%, which was lower than that of control group (38.98%, P <0.05). Conclusion: For patients with peptic ulcer, taking rehabilitation of new liquid combined with pantoprazole treatment has a significant effect, high safety, worthy of clinical application.